Bertrand Chol

Bertrand Chol is an experienced professional in the field of biotechnology and biopharmaceuticals, currently serving as the Head of R&D Bioprocess Development and GMP Production at MiGenTra GmbH since October 2022. Chol has a robust background in managing CMC development programs for biosimilar products, including monoclonal antibodies and CAR T cell therapies. Previous roles include serving as Deputy CEO (Intern) at Grapheal, guiding strategic marketing efforts, and as Biotechnological Process Development and Production Manager at Pierre Fabre, overseeing GMP biomanufacturing operations. Early career experience includes bioprocess development at PX'Therapeutics, research engineering at Merck KGaA, and vaccine manufacturing process validation at Sanofi Pasteur. Education includes a Master of Engineering in biotechnology from Polytech Clermont, an MBA from Grenoble IAE, and ongoing Executive MBA studies.